Clinical Trial Update: A Study in Asymptomatic HIV Infected Patients to Investigate Pharmacodynamics, Pharmacokinetics, Safety and Toleration of UK-453,061 [Phase 2]

View source ↗

Summary

Pfizer conducted a Phase 2 study in asymptomatic HIV-infected patients to evaluate pharmacodynamics, pharmacokinetics, safety and tolerability of the investigat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• UK-453,061

Snippet

Sponsor: Pfizer | Conditions: HIV-1 | Phase 2 | Status: COMPLETED | Results posted: 2013-10-18